News & Events
October 15, 2015
Coalition Against Major Diseases and FDA 2015 Annual Scientific WorkshopOctober 15, 2015 FDA White Oak Campus CO-SPONSORED BY: Critical Path Institute U.S. Food and Drug Administration Overview and Objectives The Coalition Against Major Diseases (CAMD) is a public-private-partnership aimed at creating new tools and methods that can be applied to increase the efficiency of the development process of new treatments for Alzheimer’s disease...
October 7, 2015
PD Imaging Biomarker Team at European Medicines Agency (EMA)Experts of the Parkinson’s disease imaging biomarker team participated in a Scientific Advice meeting at the European Medicines Agency on October 7th 2015. The purpose of this meeting was to review the evidence provided to the Agency that supports the use of Molecular Imaging of the Dopamine Transporter as an enrichment biomarker in clinical trials...
September 25, 2015
Drug Development Tools for Kidney Disease: DDT-KD Consortium Planning MeetingOn September 25th, the Critical Path Institute (C-Path), in partnership with Dr. Chirag Parikh (Yale University) and Dr. Kumar Sharma (University of California, San Diego), sponsored a meeting to launch the Drug Development Tools for Kidney Disease (DDT-KD) Consortium. Dr. Amy Porter (C-Path) will work with Dr. Parikh and Dr. Sharma as Co-Directors of this...
- August 21, 2015
May 6, 2015
Migrating a PRO InstrumentThis webinar provides a detailed description of the process for conducting paper to ePRO migration, mode-specific migrations, usability, feasibility and user acceptance testing as well as case studies of successful migrations. Presenters: Serge Bodart, MSc (Biomedical Systems) Alisandra Johnson, BS (Bracket) PDF version